AMENDMENT TO CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • March 4th, 2022 • Seelos Therapeutics, Inc. • Pharmaceutical preparations • New York
This Amendment (this “Amendment”) to that certain Convertible Promissory Note No. 1, issued on November 23, 2021 (the “Note”), in the principal amount of $22,000,000 and due November 23, 2024, by Seelos Therapeutics, Inc., a Nevada corporation (the “Company”), to Lind Global Asset Management V, LLC, a Delaware limited liability company (together with its successors and representatives, the “Holder”), is made as of December 10, 2021, by and between the Company and the Holder.
